A Registry Study of Biomarkers in Heart Valve Disease
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 200,000
- Locations
- 1
- Primary Endpoint
- All-cause death
Study Overview
Brief Summary
Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to 100 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Patients clinically diagnosed with heart valve disease in Beijing Anzhen Hospital
Exclusion Criteria
- •Age < 18 years
- •Failure to obtain medical records and ultrasound data
- •Refuse follow-up
Outcomes
Primary Outcomes
All-cause death
Time Frame: These data is collected during follow-up visit at 12 months after discharge
whether recidivation happened,whether other related disease happened
Secondary Outcomes
- HF rehospitalization(These data is collected during follow-up visit at 12 months after discharge)
